Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
All facilities producing US-market products operate under FDA registration and are subject to routine regulatory inspection
These first-generation compounds established the foundational research framework for incretin-based metabolic studies
The safety profile is generally favorable, with most side effects being GI-related (nausea, constipation, diarrhea) that improve with time and gradual dose escalation
Dig Liver Dis
Compare with similar compounds BPC-157 and TB-500 are the two most-studied tissue-repair peptides and are often examined together see the BPC-157 + TB-500 blend for combined-compound research convenience
US$ 23.48
US$ 23.44
US$ 20.65
US$ 27.39
US$ 25.32
US$ 26.74
